NXT:NASDAQNextpower Inc. Analysis
Data as of 2026-06-01 - not real-time
$156.40
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Nextpower Inc. (NXT) is trading at $156.4, comfortably above its 20‑day SMA of 130.36 and near the 30‑day resistance of $163.13, while technicals remain bullish with a RSI of 69.4 and a bullish MACD histogram. The stock exhibits high short‑term volatility (75% 30‑day) and a beta above 2, indicating pronounced sensitivity to market swings. Fundamentally, the company posted a 4.7% YoY revenue decline to $880.5 M in Q1 CY2026, yet beat earnings expectations with non‑GAAP EPS of $1.05, 13.5% above consensus, and forecasts full‑year revenue of $3.95 B, slightly ahead of estimates. Despite a solid operating margin of 18.2% and a strong ROE of 29.6%, the DCF‑derived fair value of $34.3 suggests the current price is markedly overvalued, reflected by a -4.7% upside/downside metric. The balance sheet is robust, featuring $1.15 B in cash against modest debt of $53 M, but the P/B of 10.8 and forward PE of 29 imply premium valuation. Analyst consensus leans “Buy” with a median target of $150, yet the market price already exceeds this, raising concerns of a near‑term pullback. Investors should weigh the strong earnings beat and cash strength against the high valuation, elevated volatility, and sector‑specific risks before deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance and above DCF fair value
- High volatility and beta increase short‑term uncertainty
- Recent earnings beat supports stability
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong cash position and low debt
- Operating margins and ROE remain robust
- Revenue guidance slightly above analyst estimates
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Solar sector exposure to policy and technology cycles
- Valuation premium may limit upside
- Sustainable profitability and cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth-4.70%
Profit Margin16.46%
P/E Ratio40.6
ROE29.57%
ROA12.17%
Debt/Equity2.27
P/B Ratio10.8
Op. Cash Flow$562.9M
Free Cash Flow$311.7M
Industry P/E41.9
Technical Analysis
TrendBullish
RSI69.4
Support$113.08
Resistance$163.13
MA 20$130.36
MA 50$121.76
MA 200$99.40
MACDBullish
VolumeStable
Fear & Greed Index93.27
Valuation
Fair Value$34.29
Target Price$149.00
Upside/Downside-4.73%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.03
Volatility75.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.